Physician profile
Charles Choy
NPI 1073599700
$3,130.22
in general payments reported to CMS, 2019-2025
16 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $22.21 · 2021: $81.42 · 2022: $22.26 · 2023: $227 · 2024: $2,267 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $736 · Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $735.65 |
| Food and Beverage | $505.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,251.65 | 2024 | |
| Davol INC. | $164.86 | 2025 | Phasix Mesh |
| Painteq LLC | $115.73 | 2023 | Painteq |
| Microvention, INC. | $112.29 | 2019 | |
| Covidien LP | $96.57 | 2019 | |
| Janssen Pharmaceuticals, INC | $63.73 | 2021-2023 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.83 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.87 | 2023-2025 | Gattex |
| Shionogi INC | $48.05 | 2023 | Fetroja |
| Solventum Corporation | $38.58 | 2025 | V.A.C. Veraflo Cleanse Choice, V.A.C. Dermatac, Prevena |
| W. L. Gore & Associates, INC. | $30.39 | 2021 | |
| Melinta Therapeutics, LLC | $24.48 | 2025 | Orbactiv, Kimyrsa, Rezzayo |
| Alcresta Therapeutics, INC. | $24.23 | 2023 | Relizorb |
| Boston Scientific Corporation | $22.26 | 2022 | |
| Chiesi USA, INC. | $22.21 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Choy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.